Restasis 0.05% eye emulsion 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FDA6X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,009
Award facts
- Contract value 100% obligated
- $3,008.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,008.88 to AmerisourceBergen Drug Corp for the supply of Restasis 0.05% Eye Emulsion in 30-unit quantities. The contract is non-competitive with no set-aside designation and carries a firm fixed-price structure with an ultimate completion date of January 21, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a leading pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order represents a small-value transaction executed under the company's established relationship with the Defense Logistics Agency for critical pharmaceutical supply.
This award is issued as a delivery order under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. AmerisourceBergen is the parent company of Cencora, Inc., which holds the primary IDC relationship with the Defense Logistics Agency valued at up to $999,999,999 through December 31, 2031, demonstrating the organization's critical role in federal pharmaceutical supply chains.
Quick answers
Who was awarded contract SPE2DR26FDA6X?
SPE2DR26FDA6X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FDA6X worth?
The government has obligated $3,009 on SPE2DR26FDA6X.
Is contract SPE2DR26FDA6X an order under another contract?
Yes. SPE2DR26FDA6X is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDA6X competed?
The extent of competition for SPE2DR26FDA6X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award